Vulvar, vaginal, penile, rectal cancer
Clinical trials for Vulvar, vaginal, penile, rectal cancer explained in plain language.
Never miss a new study
Get alerted when new Vulvar, vaginal, penile, rectal cancer trials appear
Sign up with your email to follow new studies for Vulvar, vaginal, penile, rectal cancer, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New HPV vaccine combo aims to fight Hard-to-Treat cancers
Disease control CompletedThis study tests an HPV vaccine (PRGN-2009) alone or with a drug called M7824 in people with HPV-positive cancers like cervical, anal, and throat cancers. The goal is to find a safe dose and see if the combination boosts the immune system's attack on tumors. The trial includes 39…
Matched conditions: VULVAR, VAGINAL, PENILE, RECTAL CANCER
Phase 1/2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Aug 20, 2026 00:00 UTC
-
Triple immunotherapy attack shows promise against Hard-to-Treat HPV cancers
Disease control CompletedThis study tests a combination of three immunotherapy drugs—PDS0101, M7824, and NHS-IL12—in people with advanced HPV-related cancers such as cervical, anal, and throat cancers. The goal is to see if the mix can shrink tumors or stop them from growing. Participants receive the dru…
Matched conditions: VULVAR, VAGINAL, PENILE, RECTAL CANCER
Phase 1/2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC